Catherine Ternisien

2.4k total citations
71 papers, 1.6k citations indexed

About

Catherine Ternisien is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Catherine Ternisien has authored 71 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 17 papers in Surgery and 14 papers in Genetics. Recurrent topics in Catherine Ternisien's work include Platelet Disorders and Treatments (40 papers), Hemophilia Treatment and Research (27 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). Catherine Ternisien is often cited by papers focused on Platelet Disorders and Treatments (40 papers), Hemophilia Treatment and Research (27 papers) and Blood Coagulation and Thrombosis Mechanisms (22 papers). Catherine Ternisien collaborates with scholars based in France, United States and Canada. Catherine Ternisien's co-authors include Paul Calès, Yves Gallois, Marc Trossaërt, Anselme Konaté, I. Hubert-Fouchard, Alain Chevailler, Dominique de Prost, Marie‐Christine Rousselet, Frédéric Oberti and Véronique Ollivier and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Catherine Ternisien

66 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Ternisien France 23 733 557 454 313 170 71 1.6k
Alaa Ahmed United States 16 347 0.5× 215 0.4× 175 0.4× 354 1.1× 60 0.4× 26 1.2k
Rudolf Pihusch Germany 21 685 0.9× 140 0.3× 120 0.3× 123 0.4× 154 0.9× 43 1.2k
Graziella Saggiorato Italy 21 459 0.6× 197 0.4× 175 0.4× 153 0.5× 196 1.2× 44 1.0k
Barry Woodhams United Kingdom 22 741 1.0× 171 0.3× 75 0.2× 145 0.5× 319 1.9× 71 1.4k
Joost C. M. Meijers Netherlands 9 359 0.5× 185 0.3× 121 0.3× 135 0.4× 166 1.0× 9 826
Hoyu Takahashi Japan 26 962 1.3× 320 0.6× 39 0.1× 226 0.7× 281 1.7× 84 1.6k
Liang-Tsai Hsiao Taiwan 15 199 0.3× 400 0.7× 291 0.6× 59 0.2× 50 0.3× 50 894
Aekaterini Sfiridaki Greece 19 332 0.5× 150 0.3× 53 0.1× 243 0.8× 84 0.5× 23 1.0k
Robert B. Francis United States 20 778 1.1× 261 0.5× 46 0.1× 203 0.6× 167 1.0× 38 1.5k
Sukesh C. Nair India 20 720 1.0× 132 0.2× 70 0.2× 123 0.4× 117 0.7× 104 1.2k

Countries citing papers authored by Catherine Ternisien

Since Specialization
Citations

This map shows the geographic impact of Catherine Ternisien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Ternisien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Ternisien more than expected).

Fields of papers citing papers by Catherine Ternisien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Ternisien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Ternisien. The network helps show where Catherine Ternisien may publish in the future.

Co-authorship network of co-authors of Catherine Ternisien

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Ternisien. A scholar is included among the top collaborators of Catherine Ternisien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Ternisien. Catherine Ternisien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sigaud, Marianne, et al.. (2024). Bleeding management in type 3 von Willebrand disease with anti‐von Willebrand factor inhibitor: A literature review and case report. SHILAP Revista de lepidopterología. 5(5). 964–970. 3 indexed citations
2.
Desprez, Dominique, Laurent Sattler, Catherine Ternisien, et al.. (2024). Efficacy and safety of a recombinant von Willebrand factor treatment in acquired von Willebrand syndrome in case of bleeding and surgical procedures. Haemophilia. 30(6). 1341–1347. 1 indexed citations
3.
Beurrier, Philippe, et al.. (2023). Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study. Transfusion. 63(12). 2321–2327. 1 indexed citations
4.
Debord, Camille, Marion Eveillard, Marc Trossaërt, et al.. (2023). Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders. European Journal Of Haematology. 111(5). 787–795.
5.
Dargaud, Yesim, Antoine Rauch, Anne Lienhart, et al.. (2023). Modèle hub & spoke en France : organisation des soins et parcours des patients pour la thérapie génique de l’hémophilie. Hématologie. 29(2). 88–106. 3 indexed citations
6.
Sigaud, Marianne, Catherine Ternisien, Marc Fouassier, et al.. (2021). Prostate interventions in patients with mild haemophilia: Safe and feasible. Haemophilia. 27(6). e659–e666. 3 indexed citations
7.
Nougier, Christophe, Emmanuelle Jeanpierre, Catherine Ternisien, et al.. (2020). Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals). European Journal Of Haematology. 105(6). 675–681. 17 indexed citations
8.
Rugeri, Lucia, Marc Fouassier, Anne Lienhart, et al.. (2020). Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience. Haemophilia. 26(6). e349–e352. 1 indexed citations
9.
Boissier, Elodie, Thomas Sénage, Isabelle Gouin‐Thibault, et al.. (2020). Heparin Anti-Xa Activity, a Readily Available Unique Test to Quantify Apixaban, Rivaroxaban, Fondaparinux, and Danaparoid Levels. Anesthesia & Analgesia. 132(3). 707–716. 19 indexed citations
10.
Trossaërt, Marc, J. Graveleau, Marianne Sigaud, et al.. (2019). The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study. Haemophilia. 25(3). 527–534. 6 indexed citations
11.
Lasne, Dominique, Claire Pouplard, Christophe Nougier, et al.. (2019). Factor VIII assays in treated hemophilia A patients. Annales de biologie clinique. 77(1). 53–65.
12.
Pouplard, Claire, Emmanuelle Jeanpierre, Dominique Lasne, et al.. (2019). Factor IX assays in treated hemophilia B patients. Annales de biologie clinique. 77(1). 41–52. 1 indexed citations
13.
Rauch, Antoine, Claudine Caron, Flavien Vincent, et al.. (2016). A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis. Thrombosis and Haemostasis. 115(5). 950–959. 9 indexed citations
14.
Veyradier, Agnès, Claudine Caron, Catherine Ternisien, et al.. (2011). Validation of the first commercial ELISA for type 2N von Willebrand’s disease diagnosis. Haemophilia. 17(6). 944–951. 16 indexed citations
15.
16.
Raucourt, Emmanuelle de & Catherine Ternisien. (2008). Bonne pratique et valeur diagnostique de la biologie : hémostase-hématologie. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 37(8). S317–S328. 3 indexed citations
17.
Cognet, F., Catherine Ternisien, Pierre Brunel, et al.. (2002). Thrombopénie induite par l’héparine : présentation d’une observation avec complications thrombotiques graves et revue de la littérature. Annales de Réadaptation et de Médecine Physique. 45(5). 216–223. 6 indexed citations
18.
Delisle, Vanessa C., Catherine Ternisien, Philippe Beurrier, & Marc Zandecki. (2000). [A rare disease but with a very high hemorrhagic risk: acquired hemophilia A].. PubMed. 58(6). 741–4. 2 indexed citations
19.
Abraham, Pierre, et al.. (1999). Does venous microemboli detection add to the interpretation of D-dimer values following orthopedic surgery?. Ultrasound in Medicine & Biology. 25(4). 637–640. 17 indexed citations
20.
Ollivier, Véronique, et al.. (1993). Interleukin 4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation. British Journal of Haematology. 85(3). 462–468. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaa Ahmed Breakdown of academic impact, for papers by Rudolf Pihusch Breakdown of academic impact, for papers by Graziella Saggiorato Breakdown of academic impact, for papers by Barry Woodhams Breakdown of academic impact, for papers by Joost C. M. Meijers Breakdown of academic impact, for papers by Hoyu Takahashi Breakdown of academic impact, for papers by Liang-Tsai Hsiao Breakdown of academic impact, for papers by Aekaterini Sfiridaki Breakdown of academic impact, for papers by Robert B. Francis Breakdown of academic impact, for papers by Sukesh C. Nair
Rankless by CCL
2026